These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 18036235)

  • 1. The dimerization domain of HIV-1 viral infectivity factor Vif is required to block virion incorporation of APOBEC3G.
    Miller JH; Presnyak V; Smith HC
    Retrovirology; 2007 Nov; 4():81. PubMed ID: 18036235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumultuous relationship between the human immunodeficiency virus type 1 viral infectivity factor (Vif) and the human APOBEC-3G and APOBEC-3F restriction factors.
    Henriet S; Mercenne G; Bernacchi S; Paillart JC; Marquet R
    Microbiol Mol Biol Rev; 2009 Jun; 73(2):211-32. PubMed ID: 19487726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-1 viral infectivity factor (Vif) alters processive single-stranded DNA scanning of the retroviral restriction factor APOBEC3G.
    Feng Y; Love RP; Chelico L
    J Biol Chem; 2013 Mar; 288(9):6083-94. PubMed ID: 23316055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vif hijacks CBF-β to degrade APOBEC3G and promote HIV-1 infection.
    Jäger S; Kim DY; Hultquist JF; Shindo K; LaRue RS; Kwon E; Li M; Anderson BD; Yen L; Stanley D; Mahon C; Kane J; Franks-Skiba K; Cimermancic P; Burlingame A; Sali A; Craik CS; Harris RS; Gross JD; Krogan NJ
    Nature; 2011 Dec; 481(7381):371-5. PubMed ID: 22190037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small molecular compounds inhibit HIV-1 replication through specifically stabilizing APOBEC3G.
    Cen S; Peng ZG; Li XY; Li ZR; Ma J; Wang YM; Fan B; You XF; Wang YP; Liu F; Shao RG; Zhao LX; Yu L; Jiang JD
    J Biol Chem; 2010 May; 285(22):16546-52. PubMed ID: 20363737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Status of APOBEC3G/F in cells and progeny virions modulated by Vif determines HIV-1 infectivity.
    Yamashita T; Nomaguchi M; Miyake A; Uchiyama T; Adachi A
    Microbes Infect; 2010 Feb; 12(2):166-71. PubMed ID: 19944180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional analysis of the two cytidine deaminase domains in APOBEC3G.
    Li X; Ma J; Zhang Q; Zhou J; Yin X; Zhai C; You X; Yu L; Guo F; Zhao L; Li Z; Zeng Y; Cen S
    Virology; 2011 Jun; 414(2):130-6. PubMed ID: 21489586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Function analysis of sequences in human APOBEC3G involved in Vif-mediated degradation.
    Zhang L; Saadatmand J; Li X; Guo F; Niu M; Jiang J; Kleiman L; Cen S
    Virology; 2008 Jan; 370(1):113-21. PubMed ID: 17916373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The HIV-1 Vif PPLP motif is necessary for human APOBEC3G binding and degradation.
    Donahue JP; Vetter ML; Mukhtar NA; D'Aquila RT
    Virology; 2008 Jul; 377(1):49-53. PubMed ID: 18499212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of tRNA₃(Lys)-primed reverse transcription by human APOBEC3G during human immunodeficiency virus type 1 replication.
    Guo F; Cen S; Niu M; Saadatmand J; Kleiman L
    J Virol; 2006 Dec; 80(23):11710-22. PubMed ID: 16971427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of small molecule compounds targeting the interaction of HIV-1 Vif and human APOBEC3G by virtual screening and biological evaluation.
    Ma L; Zhang Z; Liu Z; Pan Q; Wang J; Li X; Guo F; Liang C; Hu L; Zhou J; Cen S
    Sci Rep; 2018 May; 8(1):8067. PubMed ID: 29795228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNAJB8 facilitates autophagic-lysosomal degradation of viral Vif protein and restricts HIV-1 virion infectivity by rescuing APOBEC3G expression in host cells.
    Chand K; Barman MK; Ghosh P; Mitra D
    FASEB J; 2023 Mar; 37(3):e22793. PubMed ID: 36723955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of Enhanced HIV Restriction by Virion Coencapsidated Cytidine Deaminases APOBEC3F and APOBEC3G.
    Ara A; Love RP; Follack TB; Ahmed KA; Adolph MB; Chelico L
    J Virol; 2017 Feb; 91(3):. PubMed ID: 27881650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-1 Vif inhibits G to A hypermutations catalyzed by virus-encapsidated APOBEC3G to maintain HIV-1 infectivity.
    Wang Y; Kinlock BL; Shao Q; Turner TM; Liu B
    Retrovirology; 2014 Oct; 11():89. PubMed ID: 25304135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif.
    Mariani R; Chen D; Schröfelbauer B; Navarro F; König R; Bollman B; Münk C; Nymark-McMahon H; Landau NR
    Cell; 2003 Jul; 114(1):21-31. PubMed ID: 12859895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1 Vif binds to APOBEC3G mRNA and inhibits its translation.
    Mercenne G; Bernacchi S; Richer D; Bec G; Henriet S; Paillart JC; Marquet R
    Nucleic Acids Res; 2010 Jan; 38(2):633-46. PubMed ID: 19910370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. APOBEC3G impairs the multimerization of the HIV-1 Vif protein in living cells.
    Batisse J; Guerrero SX; Bernacchi S; Richert L; Godet J; Goldschmidt V; Mély Y; Marquet R; de Rocquigny H; Paillart JC
    J Virol; 2013 Jun; 87(11):6492-506. PubMed ID: 23576497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human apolipoprotein B mRNA-editing enzyme-catalytic polypeptide-like 3G (APOBEC3G) is incorporated into HIV-1 virions through interactions with viral and nonviral RNAs.
    Svarovskaia ES; Xu H; Mbisa JL; Barr R; Gorelick RJ; Ono A; Freed EO; Hu WS; Pathak VK
    J Biol Chem; 2004 Aug; 279(34):35822-8. PubMed ID: 15210704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A single amino acid substitution in human APOBEC3G antiretroviral enzyme confers resistance to HIV-1 virion infectivity factor-induced depletion.
    Xu H; Svarovskaia ES; Barr R; Zhang Y; Khan MA; Strebel K; Pathak VK
    Proc Natl Acad Sci U S A; 2004 Apr; 101(15):5652-7. PubMed ID: 15054139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small-molecule inhibition of human immunodeficiency virus type 1 replication by targeting the interaction between Vif and ElonginC.
    Zuo T; Liu D; Lv W; Wang X; Wang J; Lv M; Huang W; Wu J; Zhang H; Jin H; Zhang L; Kong W; Yu X
    J Virol; 2012 May; 86(10):5497-507. PubMed ID: 22379088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.